Rabbit Monoclonal Ab (Phage)

Abnova recognizes the importance of rabbit monoclonal antibody for research, development and commercialization. Technology accessibility, intellectual property, and higher cost have long hampered the widespread adoption and application of rabbit monoclonal antibody. Unlocking this barrier is critical to success of proteomics and biotech industry where traditional antibody tools such as mouse monoclonal antibody and rabbit polyclonal antibody encounter their limitations.

Abnova Rabbit Monoclonal (ARM) technology is an integrated and high throughput platform for the generation of rabbit monoclonal antibody. This service is available to everyone in the research and in vitro diagnostic community. A wide variety of antigens can be used for rabbit immunization. Rabbit possesses a broader yet non-tolerant immunologic repertoire for antibody development. A non-fusion library is created to screen for antibody clone of highest affinity and exquisite specificity. The clone is introduced into a proprietary expression vector for transient and scalable antibody production for many downstream applications. Customers can access the rabbit serum for pre-testing, antibody sequencing for antibody engineering, and purified antibody for application of interest.